SK15372003A3 - Nové kryštalické formy kyseliny 4-[4-[4-(hydroxydifenylmetyl)-1- piperidinyl]-1-hydroxybutyl]-alfa, alfa-dimetylbenzénoctovej a jej hydrochloridov - Google Patents
Nové kryštalické formy kyseliny 4-[4-[4-(hydroxydifenylmetyl)-1- piperidinyl]-1-hydroxybutyl]-alfa, alfa-dimetylbenzénoctovej a jej hydrochloridov Download PDFInfo
- Publication number
- SK15372003A3 SK15372003A3 SK1537-2003A SK15372003A SK15372003A3 SK 15372003 A3 SK15372003 A3 SK 15372003A3 SK 15372003 A SK15372003 A SK 15372003A SK 15372003 A3 SK15372003 A3 SK 15372003A3
- Authority
- SK
- Slovakia
- Prior art keywords
- fexofenadine
- organic solvent
- hours
- reaction mixture
- hydrochloride
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN484MA2001 | 2001-06-18 | ||
| PCT/US2001/023994 WO2002102777A2 (en) | 2001-06-18 | 2001-07-31 | NOVEL CRYSTALLINE FORMS OF 4-[4-[4-(HYDROXYDIPHENYLMETHYL)-1-PIPERINDINYL]-1-HYDROXYBUTYL]-α, α-DIMETHYLBENZENE ACETIC ACID AND ITS HYDROCHLORIDE |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK15372003A3 true SK15372003A3 (sk) | 2004-08-03 |
Family
ID=34566868
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK1537-2003A SK15372003A3 (sk) | 2001-06-18 | 2001-07-31 | Nové kryštalické formy kyseliny 4-[4-[4-(hydroxydifenylmetyl)-1- piperidinyl]-1-hydroxybutyl]-alfa, alfa-dimetylbenzénoctovej a jej hydrochloridov |
Country Status (20)
| Country | Link |
|---|---|
| EP (2) | EP1399422A2 (de) |
| JP (2) | JP2005507374A (de) |
| KR (1) | KR20040015734A (de) |
| CN (1) | CN100390145C (de) |
| AU (1) | AU2001278094B2 (de) |
| BG (1) | BG108435A (de) |
| BR (1) | BR0117054A (de) |
| CA (2) | CA2646802A1 (de) |
| CO (1) | CO5540340A2 (de) |
| CZ (1) | CZ20033358A3 (de) |
| EE (1) | EE200400010A (de) |
| HU (1) | HUP0401546A2 (de) |
| IL (2) | IL159266A0 (de) |
| MX (1) | MXPA03011728A (de) |
| NZ (1) | NZ530118A (de) |
| PL (1) | PL367632A1 (de) |
| RU (1) | RU2269516C2 (de) |
| SK (1) | SK15372003A3 (de) |
| WO (1) | WO2002102777A2 (de) |
| ZA (1) | ZA200309557B (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP0400299A2 (en) * | 2001-04-09 | 2007-08-28 | Teva Pharma | Polymorphs of fexofenadine hydrochloride |
| JP2005532356A (ja) | 2002-06-10 | 2005-10-27 | テバ ファーマシューティカル インダストリーズ リミティド | 塩酸フェキソフェナジンの多型体ｘｖｉ |
| GB0319935D0 (en) | 2003-08-26 | 2003-09-24 | Cipla Ltd | Polymorphs |
| US20050256163A1 (en) * | 2004-04-26 | 2005-11-17 | Ilan Kor | Crystalline forms of fexofenadine hydrochloride and processes for their preparation |
| ITMI20041143A1 (it) * | 2004-06-08 | 2004-09-08 | Dipharma Spa | Polimorfi di fexofenadina e procedimento per la loro preparazione |
| ITMI20041568A1 (it) * | 2004-07-30 | 2004-10-30 | Dipharma Spa | "polimorfi di fexofenadina base" |
| JP2008514641A (ja) * | 2004-09-28 | 2008-05-08 | テバ ファーマシューティカル インダストリーズ リミティド | 結晶形フェキソフェナジン、およびその調製方法 |
| WO2007007347A1 (en) * | 2005-07-07 | 2007-01-18 | Wockhardt Limited | Industrial process of fexofenadine hydrochloride with controlled side products |
| US20090306135A1 (en) | 2008-03-24 | 2009-12-10 | Mukesh Kumar Sharma | Stable amorphous fexofenadine hydrochloride |
| CN104072402B (zh) * | 2014-07-16 | 2016-08-17 | 昆山龙灯瑞迪制药有限公司 | 一种新结晶形式的盐酸非索非那定化合物及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4254129A (en) * | 1979-04-10 | 1981-03-03 | Richardson-Merrell Inc. | Piperidine derivatives |
| DK0766668T3 (da) * | 1994-05-18 | 2002-10-28 | Aventis Pharma Inc | Fremgangsmåde til fremstilling af vandfrie og hydratformer af som antihistaminer anvendelige piperidinderivater, polymorfer og pseudo-morfer deraf |
| US6153754A (en) * | 1995-12-21 | 2000-11-28 | Albany Molecular Research, Inc. | Process for production of piperidine derivatives |
| IN191492B (de) * | 1999-05-25 | 2003-12-06 | Ranbaxy Lab Ltd | |
| GB0018691D0 (en) * | 2000-07-28 | 2000-09-20 | Rolabo Sl | Process |
-
2001
- 2001-07-31 EE EEP200400010A patent/EE200400010A/xx unknown
- 2001-07-31 EP EP01956057A patent/EP1399422A2/de not_active Withdrawn
- 2001-07-31 JP JP2003505320A patent/JP2005507374A/ja active Pending
- 2001-07-31 RU RU2004101045/04A patent/RU2269516C2/ru not_active IP Right Cessation
- 2001-07-31 CA CA002646802A patent/CA2646802A1/en not_active Abandoned
- 2001-07-31 SK SK1537-2003A patent/SK15372003A3/sk unknown
- 2001-07-31 WO PCT/US2001/023994 patent/WO2002102777A2/en active IP Right Grant
- 2001-07-31 MX MXPA03011728A patent/MXPA03011728A/es active IP Right Grant
- 2001-07-31 CA CA002450858A patent/CA2450858C/en not_active Expired - Fee Related
- 2001-07-31 CZ CZ20033358A patent/CZ20033358A3/cs unknown
- 2001-07-31 IL IL15926601A patent/IL159266A0/xx unknown
- 2001-07-31 KR KR10-2003-7016163A patent/KR20040015734A/ko not_active Application Discontinuation
- 2001-07-31 NZ NZ530118A patent/NZ530118A/en unknown
- 2001-07-31 PL PL01367632A patent/PL367632A1/xx not_active Application Discontinuation
- 2001-07-31 CN CNB018233791A patent/CN100390145C/zh not_active Expired - Fee Related
- 2001-07-31 AU AU2001278094A patent/AU2001278094B2/en not_active Ceased
- 2001-07-31 BR BR0117054-6A patent/BR0117054A/pt not_active Application Discontinuation
- 2001-07-31 EP EP10010066A patent/EP2261209A1/de not_active Withdrawn
- 2001-07-31 HU HU0401546A patent/HUP0401546A2/hu unknown
-
2003
- 2003-12-09 ZA ZA200309557A patent/ZA200309557B/xx unknown
- 2003-12-09 IL IL159266A patent/IL159266A/en not_active IP Right Cessation
- 2003-12-11 BG BG108435A patent/BG108435A/xx unknown
- 2003-12-18 CO CO03110519A patent/CO5540340A2/es not_active Application Discontinuation
-
2007
- 2007-11-06 JP JP2007289084A patent/JP2008094848A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA03011728A (es) | 2004-07-08 |
| WO2002102777A8 (en) | 2003-10-30 |
| ZA200309557B (en) | 2004-09-14 |
| NZ530118A (en) | 2007-05-31 |
| EP2261209A1 (de) | 2010-12-15 |
| WO2002102777A2 (en) | 2002-12-27 |
| JP2008094848A (ja) | 2008-04-24 |
| CN1518540A (zh) | 2004-08-04 |
| CZ20033358A3 (en) | 2004-04-14 |
| KR20040015734A (ko) | 2004-02-19 |
| CA2646802A1 (en) | 2002-12-27 |
| EE200400010A (et) | 2004-02-16 |
| CA2450858A1 (en) | 2002-12-27 |
| RU2004101045A (ru) | 2005-06-27 |
| IL159266A (en) | 2010-11-30 |
| BR0117054A (pt) | 2004-07-27 |
| AU2001278094B2 (en) | 2006-01-12 |
| EP1399422A2 (de) | 2004-03-24 |
| HUP0401546A2 (hu) | 2004-12-28 |
| PL367632A1 (en) | 2005-03-07 |
| IL159266A0 (en) | 2004-06-01 |
| CA2450858C (en) | 2009-04-07 |
| BG108435A (en) | 2004-12-30 |
| JP2005507374A (ja) | 2005-03-17 |
| RU2269516C2 (ru) | 2006-02-10 |
| WO2002102777A3 (en) | 2003-02-27 |
| CO5540340A2 (es) | 2005-07-29 |
| CN100390145C (zh) | 2008-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20100174085A1 (en) | crystalline polymorphic forms of fexofenadine | |
| JP2008094848A (ja) | 新規な型の４−［４−［４−（ヒドロキシジフェニルメチル）−１−ピペリジニル］−１−ヒドロキシブチル］−α，α−ジメチルベンゼン酢酸及びその塩酸塩 | |
| BG61323B2 (bg) | Производни на пиперидина,тяхното получаване и използването им като лекарства | |
| US5354760A (en) | Crystalline Tiagabine monohydrate, its preparation and use | |
| MXPA03003459A (es) | Base venlafaxina cristalina y polimorfos novedosos de clorhidrato de venlafaxina, procesos para su preparacion. | |
| AU2001278094A1 (en) | Novel crystalline forms of 4-[4-[4-(hydroxydiphenylmethyl)-1-piperindinyl]-1-hydroxybutyl]-alpha, alpha-dimethylbenzene acetic acid and its hydrochloride | |
| US20080076928A1 (en) | Novel pharmaceutical salts of 1-benzyl-4-[ (5,6-dimethoxy-1-indanone)-2-yl] methyl piperidine ( Donepezil) | |
| US20060258705A1 (en) | Process for making crystalline donepezil hydrochloride monohydrate | |
| US6521758B2 (en) | Tosylate salts of 4-(p-fluorophenyl)-piperidine-3-carbinols | |
| WO2007052310A2 (en) | Polymorphs of fexofenadine hydrochloride and process for their preparation | |
| KR101125123B1 (ko) | 높은 광학적 순도의 ｓ-(-)-암로디핀을 제조하는 방법 및 그 중간생성 화합물 | |
| EP2072510A1 (de) | Kristalline Form von Azelastin | |
| US5466826A (en) | Process for preparing a physical form of pharmaceutical agent | |
| US20060264637A1 (en) | Preparation of paroxetine hydrochloride hemihydrate | |
| EP2121643B1 (de) | Neues verfahren zur herstellung von levocetirizin und zwischenprodukte davon | |
| CA2525835C (en) | Toremifene crystallization method | |
| WO2007110884A2 (en) | A process for the preparation of highly pure anhydrous fexofenadine hydrochloride | |
| KR20220127965A (ko) | 리나글립틴의 안정한 결정형 b의 제조방법 | |
| WO2009037718A2 (en) | Process for preparing 3-(2-(dimethylamino)ethyl)-n- methyl-1h-indole-5-methanesulfonamide and product thereof | |
| EP2154137A1 (de) | Kristalline Form einer Moxifloxacin-Base | |
| FR2800071A1 (fr) | Tetrahydropyridines, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| WO2007131759A1 (en) | A process for the preparation of amlodipine benzenesulfonate | |
| JP2006525256A (ja) | 高純度ｒａｃ−１−｛４−［２−ヒドロキシ−３−（５−キノリルオキシ）プロピル］−ピペラジン−１−イル｝−２，２−ジフェニルエタン−１−オン・フマレートの製造方法及び高純度ｒａｃ−１−｛４−［２−ヒドロキシ−３−（５−キノリルオキシ）プロピル］−ピペラジン−１−イル｝−２，２−ジフェニルエタン−１−オン・フマレート |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB9A | Suspension of patent application procedure |